Dose-response study of thimerosal-induced murine systemic autoimmunity

Toxicology and Applied Pharmacology

Volumn 194, Issue 2, 2004, Pages 169-179

  Havarinasab, S ^a   Lambertsson, L ^b   Qvarnstrom J ^b   Hultman, P ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

^b UMEÅ UNIVERSITY   (Sweden)

Author keywords

Autoimmunity; Ethylmercury; Mice; Thimerosal

Indexed keywords

ANTINUCLEAR ANTIBODY; DRINKING WATER; FIBRILLARIN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; MERCURY; PROTEIN ANTIBODY; THIOMERSAL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN ANTIBODY COMPLEX; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; B LYMPHOCYTE ACTIVATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; FEMALE; GENETIC SUSCEPTIBILITY; IMMUNOGLOBULIN BLOOD LEVEL; KIDNEY; LYMPH NODE; MOLECULAR WEIGHT; MOUSE; NONHUMAN;

MURINAE;

EID: 0347090543     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.taap.2003.09.006     Document Type: Article

References (55)

1. Al-Balaghi S., Möller E., Möller G., Abed-Valugerdi M. Mercury induces polyclonal B-cell activation, autoantibody production and renal immune complex deposits in young (NZB × NZW)F1 hybrids. Eur. J. Immunol. 26:1996;1519-1526.
2. Axton J. Six cases of poisoning after a parenteral organic mercury compound (Merthiolate). Postgrad. Med. J. 48:1972;962-964.
3. Ball L.K., Ball R., Pratt R.D. An assessment of thimerosal use in childhood vaccines. Pediatrics. 107:2001;1147-1154.
4. Barregård L., Svalander C., Schütz A., Westberg G., Sällsten G., Blohmé I., Mölne J., Attman P.-O., Haglind P. Cadmium, mercury and lead in kidney cortex of the general Swedish population: a study of biopsies from living kidney donors. Environ. Health Perspect. 107:1999;867-871.
5. Berlin M. Mercury in Dental-Filling Materials - An Updated Risk Analysis in Environmental Medical Terms. 2003;23-24 The Swedish Governmental Dental Care Commission, Stockholm. www.dentalmaterial.gov.se.
6. Black J. The puzzle of pink disease. J. R. Soc. Med. 92:1999;478-491.
7. Burlingame R.W., Rubin R.L. Subnucleosome structure as substrates in enzyme-linked immunosorbent assays. J. Immunol. Methods. 134:1990;187-199.
8. Chan E.K.L., Pollard K.M. Autoantibodies to ribonucleoprotein particles by immunoblotting. Rose N.R., Freidman H., Fahey J.L. Manual of Clinical Laboratory Immunology. 1992;755-761 American Society for Microbiology, Washington, D.C.
9. Clarkson T.W. The three modern faces of mercury. Environ. Health Perspect. 110(Suppl. 1):2002;11-23.
10. Drasch G., Schupp I., Riedl G., Günther G. Einfluss von amalgamfüllungen auf die quecksilberkonzentration in menschlichen organen. Dtsch. Zahnaerztl. Z. 47:1992;490-496.
11. Eneström S., Hultman P. Does amalgam affect the immune system? A controversial issue. Int. Arch. Allergy Immunol. 106:1995;180-203.
12. Fournié G., Mas M., Cautain B., Savignac M., Subra J.-F., Pelletier L., Saoudi A., Lagrange D., Calise M., Druet P. Induction of autoimmunity through bystander effects. Lessons from immunological disorders induced by heavy metals. J. Autoimmun. 16:2001;319-326.
13. Goldman L., Shannon M. Technical report: mercury in the environment: implications for pediatricians. Pediatrics. 108:2001;197-205.
14. Gonçalo M., Figueiredo A., Gonçalo S. Hypersensitivity to thimerosal: the sensitizing moiety. Contact Dermatitis. 34:1996;201-203.
15. Goter-Robinson C.J., Balazs T., Egorov I.K. Mercuric chloride-, gold sodium thiomalate-, and penicillamine-induced antinuclear antibodies in mice. Toxicol. Appl. Pharmacol. 86:1986;159-169.
16. Hultman P., Eneström S. Mercury induced antinuclear antibodies in mice: characterization and correlation with renal immune complex deposits. Clin. Exp. Immunol. 71:1988;269-274.
17. Hultman P., Eneström S. Murine mercury-induced immune-complex disease: effect of cyclophosphamide treatment and importance of T-cells. Br. J. Exp. Pathol. 70:1989;227-236.
18. Hultman P., Eneström S. Dose-response studies in murine mercury-induced autoimmunity and immune-complex disease. Toxicol. Appl. Pharmacol. 113:1992;199-208.
19. Hultman P., Hansson-Georgiadis H. Methyl-mercury induced autoimmunity in mice. Toxicol. Appl. Pharmacol. 154:1999;203-211.
20. Hultman P., Nielsen J. The effect of dose, gender and non-H-2 genes in murine mercury-induced autoimmunity. J. Autoimmun. 17:2001;27-37.
21. Hultman P., Nielsen J.B. The effect of toxicokinetics on murine mercury-induced autoimmunity. Environ. Health Perspect. 77:1998;141-148.
22. Hultman P., Eneström S., Skogh T. Circulating and tissue immune complexes in mercury-treated mice. J. Clin. Lab. Immunol. 29:1989;175-183.
23. Hultman P., Bell L.J., Eneström S., Pollard K.M. Murine susceptibility to mercury: I. Autoantibody profiles and systemic immune deposits in inbred, congenic, and intra-H-2-recombinant strains. Clin. Immunol. Immunopathol. 65:1992;98-109.
24. Hultman P., Ganowiak K., Turely S.J., Pollard K.M. Genetic susceptibility to silver-induced antifibrillarin autoantibodies in mice. J. Autoimmun. 77:1995;191-197.
25. Hultman P., Turley S.J., Eneström S., Lindh U., Pollard K.M. Murine genotype influences the specificity, magnitude and persistence of murine mercury-induced autoimmunity. J. Autoimmun. 9:1996;139-149.
26. Izui S., Kobayakawa T., Zryd M.J., Louis J., Lambert P.H. Mechanism for induction of anti-DNA antibodies by bacterial lipopolysaccharides in mice: II. Correlation between anti-DNA induction and polyclonal antibody formation by various polyclonal B lymphocyte activators. J. Immunol. 119:1977;2157-2168.
27. Jacobson D.L., Gange S.J., Rose N.R., Graham N.M.H. Epidemiology and estimated population burden of selected autoimmune disease in the United States. Clin. Immunol. Immunopathol. 84:1997;223-243.
28. Johansson U., Hansson-Georgiadis H., Hultman P. Murine silver-induced autoimmunity: silver shares induction of antinucleolar antibodies with mercury, but causes less activation of the immune system. Int. Arch. Allergy Immunol. 113:1997;432-443.
29. Johansson U., Hansson-Georgiadis H., Hultman P. The genotype determines the B cell response in mercury-treated mice. Int. Arch. Allergy Immunol. 116:1998;295-305.
30. Kazantzis G., Schiller K.F.R., Asscher A.W., Drew R.G. Albuminuria and the nephrotic syndrome following exposure to mercury and its compounds. Q. J. Med. 31:1962;403-418.
31. Magos L. Review on the toxicity of ethylmercury, including its presence as a preservative in biological and pharmaceutical products. J. Appl. Toxicol. 21:2001;1-5.
32. Magos L. Neurotoxic character of thimerosal and the allometric extrapolation of adult clearance half-time to infants. J. Appl. Toxicol. 23:2003;263-269.
33. Magos L., Brown A.W., Sparrow S., Bailey E., Snowden R.T., Skipp W.R. The comparative toxicology of ethyl- and methylmercury. Arch. Toxicol. 57:1985;260-267.
34. Maibach H. Acute laryngeal obstruction presumed secondary to thimerosal (Merthiolate) delayed hypersensitivity. Contact Dermatitis. 1:1975;221.
35. Matheson D., Clarkson T., Gelfand E. Mercury toxicity (acrodynia) induced by long-term injection of gamma globulin. J. Pediatr. 97:1980;153-155.
36. 2-induced antinucleolar antibodies. Eur. J. Immunol. 12:1989;2257-2261.
37. National Toxicology Program Chemical Health and Safety Information: O-Carboxyphenyl-thio-ethylmercury Sodium Salt. 2003;National Institute of Environmental Health Sciences, Research Triangle Park, NC.
38. Nielsen J.B. Toxicokinetics of mercuric chloride and methylmercuric chloride in mice. J. Toxicol. Env. Health. 37:1992;85-122.
39. Nielsen J.B., Hultman P. Mercury-induced autoimmunity in mice. Environ. Health Perspect. 110:2002;S5877-S5881.
40. Pollard K.M., Hultman P. Effects of mercury on the immune system. Sigel H., Sigel A. Mercury and Its Effects on Environment and Biology. 1997;421-440 Marcel Dekker, Basel.
41. Pollard K.M., Pearson D.L., Hultman P., Hildebrandt B., Kono D.H. Lupus-prone mice as models to study xenobiotic-induced acceleration of systemic autoimmunity. Environ. Health Perspect. 107:1999;729-735.
42. Pollard K.M., Pearson D.L., Hultman P., Deane T.N., Lindh U., Kono D.H. Xenobiotic acceleration of idiopathic systemic autoimmunity in lupus prone BXSB mice. Environ. Health Perspect. 109:2001;27-33.
43. Qvarnström J., Lambertsson L., Havarinasab S., Hultman P., Frech W. Determination of methylmercury, ethylmercury, and inorganic mercury in mouse tissues, following administration of thimerosal, by species-specific isotope dilution GC-inductively coupled plasma-MS. Anal. Chem. 75:2003;4120-4124.
44. Santucci B., Cannistraci C., Cristaudo A., Camera E., Picardo M. Thimerosal positives: the role of organomercury alkyl compounds. Contact Dermatitis. 38:1998;325-328.
45. Stratton K., Gable A., McCormick M.C. Thimerosal-Containing Vaccines and Neurodevelopmental Disorders. 2001;Institute of Medicine, Washington, DC.
46. Suneja T., Belsito D. Thimerosal in the detection clinically relevant allergic contact reactions. J. Am. Acad. Pathol. 45:2001;23-27.
47. Suzuki T., Miyama T., Katsunuma H. Comparative study of bodily distribution of mercury in mice after subcutaneous administration of methyl, ethyl, and n-propyl mercury acetates. Jpn. J. Exp. Med. 33:1963;277-282.
48. Suzuki T., Takemoto T.-I., Kashiwazaki H., Miyama T. Metabolic fate of ethylmercury salts in man and animal. Miller M., Clarkson T. Mercury, Mercurials and Mercaptans. 1973;209-232 Charles C. Thomas, Springfield, IL.
49. Takeuchi K., Turley S.J., Tan E.M., Pollard K.M. Analysis of the autoantibody response to fibrillarin in human disease and murine models of autoimmunity. J. Immunol. 154:1995;691-699.
50. Ulfvarson U. Distribution and excretion of some mercury compounds after long term exposure. Int. Arch. Gewerbepathol. Gewerbehyg. 19:1962;412-422.
51. van't Veen A.J., van Joost T. Sensitization to thimerosal (Merthiolate) is still present today. Contact Dermatitis. 31:1994;293-298.
52. Warfvinge K., Hansson H., Hultman P. Systemic autoimmunity due to mercury vapor in genetically susceptible mice: dose-response studies. Toxicol. Appl. Pharmacol. 132:1995;299-309.
53. Westphal G.A., Schnuch A., Schulz T.G., Reich K., Aberer W., Brasch J., Koch P., Wessbecher R., Szliska C., Bauer A., Hallier E. Homozygous gene deletions of the glutathione S-transferase MI and TI are associated with thimerosal sensitization. Int. Arch. Occup. Environ. Health. 73:2000;384-388.
54. Wöhrl S., Hemmer W., Focke M., Götz M., Jarisch R. Patch testing in children, adults, and the elderly: influence of age and sex on sensitization patterns. Pediatr. Dermatol. 20:2003;119-123.
55. Zenarola P., Gimma A., Lomuto M. Systemic contact dermatitis from thimerosal. Contact Dermatitis. 32:1995;107-123.